Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bacterial protein kills tumors

28.10.2002


New weapon in the fight against cancer?



The use of live bacteria to treat cancer goes back a hundred years. But while the therapy can sometimes shrink tumors, the treatment usually leads to toxicity, limiting its value in medicine.

Now, researchers at the University of Illinois at Chicago have isolated a protein secreted by bacteria that kills cancer cells but appears to have no harmful side effects. Tested in mice injected with human melanomas, the protein shrank the malignancies, but, in contrast with other studies using whole bacteria, caused no deaths or adverse reactions in the laboratory animals.


"Bacterial proteins could well be a new weapon in the war against cancer," said Ananda Chakrabarty, distinguished professor of microbiology and immunology and one of the study’s investigators.

Results of the three-year-long study are published in the October 29 issue of the Proceedings of the National Academy of Sciences.

Oddly, the protein the researchers isolated is a well-studied molecule called azurin that is involved in the everyday process cells use to generate energy. This is the first report, however, that azurin is an effective anticancer agent.

The protein was isolated from the growth medium of Pseudomonas aeruginosa, a bacterium that is often resistant to antibiotics and causes serious respiratory infections in people who are particularly susceptible, such as patients with cystic fibrosis or severe burns. The bacterium protects itself from destruction by killing macrophages, the immune system’s first line of attack against a foreign body.

In the UIC study, specially-bred immunodeficient mice implanted with human melanoma were treated with half a milligram of azurin daily for 22 days. At the conclusion of the trial, the average size of the tumors in these mice was 60 percent smaller than those in untreated mice. None of the mice showed signs of illness or loss of weight.

The researchers said that azurin appears to work by stabilizing the p53 protein, a product of the p53 gene, known as a tumor suppressor because it prevents the formation of cancers through a cascade of molecular events that either stops cells from dividing or induces a process called programmed cell death. Normally, the p53 protein is short-lived, surviving just a few minutes in the cell before degrading. But azurin winds its way into the nucleus of the tumor cell, where it binds to the p53 protein and protects it from degradation, thus raising its level within the cell.

According to Dr. Tapas Das Gupta, a co-investigator and head of surgical oncology at UIC, preliminary data show that azurin kills several types of cancer cells, including breast and colon cancer.

"These results suggest that azurin could be a useful anticancer agent not just for melanoma but for different kinds of tumors," Das Gupta said. But he cautioned that extensive studies are needed to confirm the inital laboratory results.

The first observation that bacteria can thwart tumors was made in 1893 by New York physician William Coley, who found that bone cancer patients who contracted bacterial infections survived longer.

Much more recently, researchers at Johns Hopkins University used anaerobic bacteria, bacteria that thrive without oxygen, to destroy the hard cores of tumors. Radiation and chemotherapy are ineffective in these areas because they lack blood and oxygen. In the Hopkins studies, whole "de-fanged" bacteria were used. But although their tumors shrank, a large proportion of the experimental mice died, presumably because of toxins released either by the bacteria or the dying cancer cells.

"Our research suggests we can achieve a therapeutic outcome using bacterial proteins, without the toxicity associated with live bacteria," Chakrabarty said.


Other authors of the study were UIC researchers Tohru Yamada, Masatoshi Goto, Vasu Punj, Olga Zaborina, Mei Ling Chen, Kazuhide Kimbara, Dibyen Majumdar and Elizabeth Cunningham.

The study was supported by grants from the National Institute of Environmental Health Sciences, the National Institute of Allergy and Infectious Diseases and the National Cancer Institute.

Sharon Butler | EurekAlert!
Further information:
http://www.uic.edu

More articles from Health and Medicine:

nachricht World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern

nachricht Therapy of preterm birth in sight?
19.07.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

Stanford researchers develop a new type of soft, growing robot

21.07.2017 | Power and Electrical Engineering

Vortex photons from electrons in circular motion

21.07.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>